Announced Sat, 24 Oct, 2026 · 22:07 IST

Consolidated Q2 revenue and profit fall; auditor cannot conclude on results

Going ConcernQualified OpinionEmphasis Of MatterRevenue DeclineNegative Operating CashflowResults View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-4.9%Reaction day
₹1.82
prior close
₹1.73
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-5.3% vs market
Trading - Chemicals peers, median of 13sector+3.8%-8.8% vs sector

On the reaction day the stock moved 5.3 pts less than Nifty Microcap 250 and 8.8 pts less than its Trading - Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
+0.0
15m
+0.0
30m
+0.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-4.9+0.4-5.3+3.8-8.8
Next day
-9.3+2.1-11.5+3.6-12.9
2d
-13.7pendingpending+3.0-16.7
3d
—————
4d
—————
5d
—————
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Trading - Chemicals peers, median of 13Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved Q2 and half-year unaudited results for September 2026. Consolidated operating revenue fell 19.0% year on year to Rs. 2,501.84 lakh and net profit fell 45.0% to Rs. 23.10 lakh. Bond conversion added 34.07 crore shares in the quarter. The auditor could not conclude, citing loans of Rs. 735.13 lakh and trade receivables of Rs. 2,943.89 lakh without expected-loss assessment. A suspended subsidiary had negative net worth.

Likely market impact

Consolidated revenue and profit fell; 34.07 crore new shares dilute ownership. Receivable and subsidiary doubts also raise share-price risk.